Skip to content

UNANI FORMULATION IN PATIENTS OF CHRONIC RHINO SINUSITIS

CLINICAL STUDY OF A UNANI FORMULATION WITH INKEBAB (MEDICATED INHALATION) IN THE TREATMENT OF ILTEHAB TAJAWEEFE ANAF MUZMIN (CHRONIC RHINO SINUSITIS)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013353
Enrollment
60
Registered
2018-04-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Chronic Rhinosinusitis

Interventions

Intervention1: Test Drug A (Test Group-I):-Composition of oral drug 1. Katan (Linum utitassimum Linn.) 10.0gm/day 2. Filfil Siyah (Piper nigrum Linn.) 2.0gm/day 3. Honey 10.0gm/day FOR I

Sponsors

Jamia Hamdard
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with chronic Rhinosinusitis as per the diagnostic criteria,Impaired quality of life, as measured by the Rhinosinusitis Disability Index (RSDI),Willing to participate in the study

Exclusion criteria

Exclusion criteria: Pregnancy,Use of any other investigational agent in the last 30 days, Chronic or intermittent use of inhaled, oral, intramuscular, intravenous, and/or potent Steroids,Diabetes mellitus,CRF,Hepatic Failure

Design outcomes

Primary

MeasureTime frame
Clinical Parameter Symptomatic Response(SR)Quality Of Life Assessment Sino Nasal Outcome Test (SNOT-22)Rhino Sinusitis Disability Index(RSDI)Ige AEC CBC ESR LFT KFTTimepoint: Assessments of the patients were made Pre treatment and Post treatment

Secondary

MeasureTime frame
Radiological Assessmenent X-ray PNS Waterâ??s View CT scans PNS Nasal Swab culture and sensitivity test & cytology were performedTimepoint: The assessments of the patients were made Pre treatment and Post treatment

Countries

India

Contacts

Public ContactAzhar Jabin

jamia hamdard

zehra.zaidi@jamiahamdard.ac.in09868966508

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026